Influence of therapy on antibody-formation (Q70545797)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5098938%20AND%20SRC:MED&resulttype=core&format=json

reason for deprecated rank

12 October 2019

title

Die Wirkung der Neuroleptica-Behandlung auf die Antikörperbildung (German)

marking inconsistent with the registered/official identifier/name

1 reference

reason for deprecated rank

16 April 2023

Influence of therapy on antibody-formation (English)

marking inconsistent with the registered/official identifier/name

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5098938

16 April 2023

1 reference

16 April 2023

author name string

M. Ozek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5098938

16 April 2023

K. Töreci

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5098938

16 April 2023

I. Akkök

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5098938

16 April 2023

Z. Güvener

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5098938

16 April 2023

language of work or name

German

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=5098938

16 April 2023

publication date

1 January 1971

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5098938%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

12 October 2019

http://link.springer.com/content/pdf/10.1007/BF02419063.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF02419063/fulltext.html

16 April 2023

1 reference

http://link.springer.com/content/pdf/10.1007/BF02419063

16 April 2023

1 reference

16 April 2023

21

4

401–12

1971

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=5098938

16 April 2023

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5098938%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5098938%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

page(s)

401-412

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5098938%20AND%20SRC:MED&resulttype=core&format=json

Schizophrenia as an immunologic disorder. I. Demonstration of antibrain globulins by fluorescent antibody techniques.

12 October 2019

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02419063

Schizophrenia as an immunologic disorder. II. Effects of serum protein fractions on brain function.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02419063

The protein profile in chlorpromazine therapy.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/5098938

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[Studies on the problem of pharmacological control of the blood protein spectrum.]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/5098938

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/BF02419063

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5098938%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference